424 related articles for article (PubMed ID: 22075983)
1. BCL2A1: the underdog in the BCL2 family.
Vogler M
Cell Death Differ; 2012 Jan; 19(1):67-74. PubMed ID: 22075983
[TBL] [Abstract][Full Text] [Related]
2. Prenylated Rab acceptor RABAC1 inhibits anti-apoptotic protein BCL2A1 and induces apoptosis.
Kim JT; Cho HJ; Cho MY; Lim J; Park ES; Lim JS; Lee HG
Biochem Biophys Res Commun; 2019 Jun; 513(4):940-946. PubMed ID: 31003775
[TBL] [Abstract][Full Text] [Related]
3. Cloning of the bovine antiapoptotic regulator, BCL2-related protein A1, and its expression in trophoblastic binucleate cells of bovine placenta.
Ushizawa K; Takahashi T; Kaneyama K; Hosoe M; Hashizume K
Biol Reprod; 2006 Feb; 74(2):344-51. PubMed ID: 16221993
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy.
Li X; Dou J; You Q; Jiang Z
Eur J Med Chem; 2021 Aug; 220():113539. PubMed ID: 34034128
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
Sagara A; Igarashi K; Otsuka M; Karasawa T; Gotoh N; Narita M; Kuzumaki N; Narita M; Kato Y
PLoS One; 2016; 11(10):e0164250. PubMed ID: 27723829
[TBL] [Abstract][Full Text] [Related]
6. Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival.
Sochalska M; Ottina E; Tuzlak S; Herzog S; Herold M; Villunger A
Cell Death Differ; 2016 Apr; 23(4):628-39. PubMed ID: 26450454
[TBL] [Abstract][Full Text] [Related]
7. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.
Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ
J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming cell death: BCL2 family inhibition in hematological malignancies.
Scarfò L; Ghia P
Immunol Lett; 2013; 155(1-2):36-9. PubMed ID: 24095849
[TBL] [Abstract][Full Text] [Related]
10. Retinoid x receptor agonists increase bcl2a1 expression and decrease apoptosis of naive T lymphocytes.
Rasooly R; Schuster GU; Gregg JP; Xiao JH; Chandraratna RA; Stephensen CB
J Immunol; 2005 Dec; 175(12):7916-29. PubMed ID: 16339527
[TBL] [Abstract][Full Text] [Related]
11. Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins.
D de Araujo A; Lim J; Wu KC; Xiang Y; Good AC; Skerlj R; Fairlie DP
J Med Chem; 2018 Apr; 61(7):2962-2972. PubMed ID: 29584430
[TBL] [Abstract][Full Text] [Related]
12. Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2.
Timucin AC; Basaga H
Free Radic Biol Med; 2017 Oct; 111():209-218. PubMed ID: 27840321
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax.
Werner AB; de Vries E; Tait SW; Bontjer I; Borst J
J Biol Chem; 2002 Jun; 277(25):22781-8. PubMed ID: 11929871
[TBL] [Abstract][Full Text] [Related]
15. µ-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis.
Valero JG; Cornut-Thibaut A; Jugé R; Debaud AL; Giménez D; Gillet G; Bonnefoy-Bérard N; Salgado J; Salles G; Aouacheria A; Kucharczak J
PLoS One; 2012; 7(6):e38620. PubMed ID: 22745672
[TBL] [Abstract][Full Text] [Related]
16. The novel double-hit, t(8;22)(q24;q11)/MYC-IGL and t(14;15)(q32;q24)/IGH-BCL2A1, in diffuse large B-cell lymphoma.
Akasaka T; Kishimori C; Fukutsuka K; Nakagawa M; Takeoka K; Hayashida M; Honjo G; Ohno H
Cancer Genet; 2017 Aug; 214-215():26-31. PubMed ID: 28595732
[TBL] [Abstract][Full Text] [Related]
17. BCL-2 family isoforms in apoptosis and cancer.
Warren CFA; Wong-Brown MW; Bowden NA
Cell Death Dis; 2019 Feb; 10(3):177. PubMed ID: 30792387
[TBL] [Abstract][Full Text] [Related]
18. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.
Zong WX; Edelstein LC; Chen C; Bash J; Gélinas C
Genes Dev; 1999 Feb; 13(4):382-7. PubMed ID: 10049353
[TBL] [Abstract][Full Text] [Related]
19. Role of the pro-survival molecule Bfl-1 in melanoma.
Hind CK; Carter MJ; Harris CL; Chan HT; James S; Cragg MS
Int J Biochem Cell Biol; 2015 Feb; 59():94-102. PubMed ID: 25486183
[TBL] [Abstract][Full Text] [Related]
20. TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.
Lionnard L; Duc P; Brennan MS; Kueh AJ; Pal M; Guardia F; Mojsa B; Damiano MA; Mora S; Lassot I; Ravichandran R; Cochet C; Aouacheria A; Potts PR; Herold MJ; Desagher S; Kucharczak J
Cell Death Differ; 2019 May; 26(5):902-917. PubMed ID: 30042493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
